Blood-based Biomarkers for Diagnosis of Alzheimer's
Dementia Alzheimers
About this trial
This is an interventional diagnostic trial for Dementia Alzheimers focused on measuring Alzheimer's dementia, Diagnosis, Biomarkers, Clinical practice
Eligibility Criteria
Inclusion Criteria:
- Patients where the GP suspects "dementia" (or disease leading to dementia).
- Subjective cognitive decline, i.e. patient, an informant, or the clinician suspect decline of memory or other cognitive functioning.
- Clinical evaluation is consistent with cognitive impairment, based on history, clinical examination or cognitive screening
Exclusion Criteria:
- Severe dementia with lack of capacity for consent as judged by the GP.
- Previously diagnosed dementia.
- Major psychiatric disease, use of medication, or physical disease, which according to the GP may affect participation or likely contribute significantly to the observed cognitive impairment.
- Patients who do not want to be referred to the memory outpatient clinic.
Sites / Locations
- Stavanger University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Patients with positive blood test for biomarkers for Alzheimer's disease
Patients with negative blood test for biomarkers for Alzheimer's disease
The positive blood tests results for this group will be compared with the results from the investigation at the at the memory outpatient clinic to calculate the number of false positive blood tests (using the results from the outpatient clinic as a "gold standard" for the diagnosis)
The negative blood tests results for this group will be compared with the results from the investigation at the at the memory outpatient clinic to calculate the number of false negative blood tests (using the results from the outpatient clinic as a "gold standard" for the diagnosis)